2689.T

The company maintains a conservative capital structure with a debt-to-equity ratio of 0.24, indicating a relatively low reliance on debt financing. Its liquidity position is characterized by a current ratio of 1.24, suggesting the company has sufficient short-term assets to cover its short-term liabilities. The company's liquidity FPT (free cash flow to total debt) is not explicitly provided, but the operating cash flow of 1,687,581,000 JPY supports its ability to service obligations. The price-to-book ratio of 0.99 suggests the market values the company slightly below its book value, which may reflect cautious investor sentiment or asset-heavy operations.

Profitability metrics show a return on equity (ROE) of 11.67%, which is strong compared to the industry median for medical equipment and distribution firms. However, the return on assets (ROA) of 3.12% is relatively modest, indicating that the company is not leveraging its asset base as effectively as some peers. The operating margin is 1.58% (calculated from operating income of 1,935,748,000 JPY on revenue of 122,702,463,000 JPY), which is below the industry median for this sector, suggesting potential inefficiencies in cost control or pricing power.

The company's revenue is concentrated in a single business segment, as disclosed in the financial snapshot, with no geographic breakdown provided. This lack of diversification may expose the company to regional economic or regulatory risks. The absence of segment or geographic data limits the ability to assess exposure to high-growth or high-risk markets.

The company's growth trajectory is modest, with no specific revenue growth rate provided in the input data. However, the outlook for the current fiscal year suggests a stable or slightly positive direction, with no significant changes in revenue expected. The company's capital expenditure of -1,609,137,000 JPY indicates a reduction in investment, which may signal a focus on cost containment or a shift in strategic priorities.

Risk factors include a low liquidity risk and a low dilution risk, as per the risk assessment. The company has no immediate filing-based liquidity or dilution flags, and the number of shares outstanding has not changed between basic and diluted shares, indicating no near-term dilution pressure. The absence of significant debt and the presence of 3,470,220,000 JPY in cash and equivalents further support the company's financial stability.

Recent events, as reflected in the financial data, include a stable earnings performance with a last actual EPS of 241.43 JPY and a revenue of 122,702,460,000 JPY. No specific filings or transcripts are provided in the input data, so the narrative is limited to the financial performance and risk assessment.